- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.05. | Sarepta shares fall amid FDA's CBER appointment and weak Elevidys sales | ||
| 07.05. | Solve FSHD to invest in Armatus Bio for ARM-201 development | ||
| 07.05. | Expediting parallel drug approval pathways is challenging, but rewarding | ||
| 07.05. | EC approves AstraZeneca's Calquence combo to treat MCL | ||
| 06.05. | Eli Lilly signs $415m deal for Alchemab's ALS therapy | ||
| 06.05. | Pharma M&A deal value surges by 101% QoQ in Q1 2025 despite US political turbulence | ||
| 06.05. | Recursion axes drug programmes to streamline pipeline | ||
| 06.05. | Veraxa and OmniAb to develop bispecific ADC tumour programme | ||
| 06.05. | US government exercises $144m option for smallpox/mpox vaccine contract | ||
| 06.05. | GLP-1 receptor agonists poised to redefine treatment paradigms beyond diabetes and obesity | ||
| 06.05. | Bristol Myers Squibb announces $40bn US investment plan over five years | ||
| 06.05. | Swiss biotech sector's R&D investment grew in 2024 despite global trends | ||
| 06.05. | FDA approves Selarsdi injection as interchangeable with Stelara | ||
| 05.05. | Chinese regulator grants priority review for InnoCare's solid tumour treatment | ||
| 05.05. | FDA accepts Novo Nordisk's NDA submission for weight management therapy | ||
| 02.05. | Q1 earnings pulse check: companies tentative on pharma-specific tariffs | ||
| 02.05. | MHRA authorises Bavarian Nordic's chikungunya virus vaccine | ||
| 02.05. | Entering the era of prenatal gene therapies | ||
| 02.05. | HHS launches $500m universal vaccines initiative | ||
| 02.05. | FDA awards RMAT status to 4DMT diabetic macular oedema therapy | ||
| 02.05. | PTSD market expected to reach $5.5bn across the 7MM by 2034 | ||
| 02.05. | Repare signs out-licensing deal with DCx Biotherapeutics | ||
| 01.05. | Biogen's Q1 revenue soars past estimates as rare disease pivot pays off | ||
| 01.05. | Lilly's Q1 2025 revenue jumps 45%, but CVS shift boosts Novo's Wegovy | ||
| 01.05. | New £1bn cancer research hub planned for South London |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .